drugset / Trial / NCT00547300

Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension

NCT00547300

Phase 3 Terminated 49 enrolled Forest Laboratories Mylan Laboratories · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study was to compare the tolerability of nebivolol to metoprolol ER in a general population of patients with mild to moderate hypertension receiving hydrochlorothiazide (HCTZ)

Timeline

Start
2007-10-31
Primary completion
2008-01-02
Completion
2008-01-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol ER Unknown 50 mg Oral
Comparator Metoprolol ER Unknown 100 mg Oral
Comparator Metoprolol ER Unknown 200 mg Oral
Subject Nebivolol Other / unclassified 5 mg Oral
Subject Nebivolol Other / unclassified 10 mg Oral
Subject Nebivolol Other / unclassified 20 mg Oral

Indications